The biologic role of interleukin-8: Functional analysis and expression of CXCR1 and CXCR2 on human eosinophils

Blood

Volumn 93, Issue 2, 1999, Pages 694-702

  Petering, Holger ^b   Götze, Otto ^b   Kimmig, Daniela ^b   Smolarski, Regina ^b   Kapp, Alexander ^b   Elsner, Jörn ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CYTOKINE; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CHEMOTAXIS; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0344628903     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.2.694.402k31_694_702     Document Type: Article

References (47)

1. Adams DH, Lloyd AR: Chemokines: Leucocyte recruitment and activation cytokines. Lancet 349:490, 1997
2. Baggiolini M, Dewald B, Moser B: Human chemokines: An update. Annu Rev Immunol 15:675, 1997
3. Ahuja SK, Murphy PM: The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists tor the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271:20545, 1996
4. Petering H, Hochstetter R, Kimmig D, Smolarski R, Kapp A, Elsner J: Detection of MCP-4 in dermal ribroblasts and its activation of the respiratory burst in human eosinophils. J Immunol 160:555, 1998
5. Elsner J, Hochstetter R, Kimmig D, Kapp A: Human eotaxin represents a potent activator of the respiratory hurst of human eosinophils. Eur J Immunol 26:1919, 1996
6. Kapp A, Zeck Kapp G, Czech W, Schöpf E: The chemokine RANTES is more than a chemoattractant: Characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol 102:906, 1994
7. Moser B, Schumacher C, von Tscharner V, Clark-Lewis I, Baggiolini M: Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem 266: 10666, 1991
8. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280, 1991
9. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 253:1278, 1991
10. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI: Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 267:16283, 1992
11. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M: Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93:6682, 1996
12. Wuyts A, Van Osselaer N, Haelens A, Samson I, Herdewijn P, Ben-Baruch A, Oppenheim JJ, Proost P, Van Damme J: Characterisation of synthetic human granulocyte chemotactic protein 2: Usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 36:2716, 1997
13. Donnelly SC, Stricter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C: Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341:643, 1993
14. Schweizer RC, Welmers BA, Raaijmakers JA, Zanen P, Lammers JW, Koenderman L: RANTES-and interleukm-8-induced responses in normal human eosinophils: Effects of priming with interleukin-5. Blood 83:3697, 1994
15. Sehmi R, Cromwell O, Wardlaw AJ, Moqbel R, Kay AB: Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 23:1027, 1993
16. Schröder JM, Mrowietz U, Morita E, Christophers E: Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 139:3474, 1987
17. Leonard EJ: NAP-1 (IL-8) (letter). Immunol Today 11:223, 1990
18. Braun RK, Franchini M, Erard F, Rihs S, De Vries IJ, Blaser K, Hansel TT, Walker C: Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 23:956, 1993
19. Kita H, Abu-Ghazaleh RI, Sur S, Gleich GJ: Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. J Immunol 154:4749, 1995
20. Yousefi S, Hemmann S, Weber M, Holzer C, Hartung K, Blaser K, Simon HU: IL-8 is expressed by human peripheral blood eosinophils. Evidence for increased secretion in asthma. J Immunol 154:5481, 1995
21. Miyamasu M, Hirai K, Takahashi Y, Iida M, Yamaguchi M, Koshino T, Takaishi T, Morita Y, Ohta K, Kasahara T: Chemotactic agonists induce cytokine generation in eosinophils. J Immunol 154: 1339, 1995
22. Nakajima H, Gleich GJ, Kita H: Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J Immunol 156:4859, 1996
23. Samanta AK, Oppenheim JJ, Matsushima K: Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 265:183, 1990
24. Schnyder-Candrian S, Strieter RM, Kunkel SL, Walz A: Interferon-α and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes. J Leukoc Biol 57:929, 1995
25. Elsner J, Oppermann M, Czech W, Dobos G, Schöpf E, Norgauer J, Kapp A: C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils. Eur J Immunol 24:518, 1994
26. 3 and all-trans retinoic acid. Eur J Immunol 27:935, 1997
27. Elsner J, Hochstetter R, Spiekermann K, Kapp A: Surface and mRNA expression of the CD52 antigen by human eosinophils but not by neutrophils. Blood 88:4684, 1996
28. Elsner J, Oppermann M, Czech W, Kapp A: C3a activates the respiratory burst in human polymorphonuclear neutrophilic leukocytes via pertussis toxin-sensitive G-proteins. Blood 83:3324, 1994
29. Combadiere C, Ahuja SK, Murphy PM: Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 270:16491, 1995
30. Schröder JM: Identification and structural characterization of chemokines in lesional skin material of patients with inflammatory skin disease. Methods Enzymol 288:266, 1997
31. Elsner J, Dichmann S, Dobos GJ, Kapp A: Actin polymerization in human eosinophils, unlike human neutrophils, depends on intracellular calcium mobilization. J Cell Physiol 167:548, 1996
32. 2+ measurement. J Biol Chem 262:6308, 1987
33. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440, 1985
34. Oin S, LaRosa G, Campbell JJ, Smith-Heath H, Kassam N, Shi X, Zeng L, Butcher EC, Mackay CR: Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: Correlation with transendothelial chemotactic potential. Eur J Immunol 26:640, 1996
35. Morohashi H, Miyawaki T, Nomura H, Kuno K, Murakami S, Matsushima K, Mukaida N: Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 57:180, 1995
36. Chuntharapai A, Lee J, Hebert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor a and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682, 1994
37. Ward SG, Westwick J: Chemokines: Understanding their role in T-lymphocyte biology. Biochem J 333:457, 1998
38. Virchow JC Jr, Kroegel C, Walker C, Matthys H: Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J Allergy Clin Immunol 98:527, 1996
39. Terkeltaub R, Zachariae C, Santoro D, Martin J, Peveri P, Matsushima K: Monocyte-derived neutrophil chemotactic factor/ interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum 34:894, 1991
40. Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397, 1996
41. Schröder JM: Cytokine networks in the skin. J Invest Dermatol 105:205, 1995
42. Erger RA, Casale TB: Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium. Am J Physiol 268:L117, 1995
43. Kernen P, Wymann MP, von Tscharner V, Deranleau DA, Tai PC, Spry CJ, Dahinden CA, Baggiolini M: Shape changes, exocytosis, and cytosolic free calcium changes in stimulated eosinophils. J Clin Invest 87:2012, 1991
44. Collins PD, Weg VB, Faccioli LH, Watson ML, Moqbel R, Williams TJ: Eosinophil accumulation induced by human interleukin-8 in the guinea-pig in vivo. Immunology 79:312, 1993
45. Warringa RA, Mengelers HJ, Raaijmakers JA, Bruijnzeel PL, Koenderman L: Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. J Allergy Clin Immunol 91:1198, 1993
46. Kapp A, Zeck-Kapp G: Interleukin-5 induced granulocyte activation in atopic patients. Br J Dermatol 125:108, 1991
47. Sanderson CJ: Interleukin-5, eosinophils, and disease. Blood 79:3101, 1992